Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

HIV-1 Vif Antibodies

Santa Cruz Biotechnology offers a broad range of HIV-1 Vif monoclonal antibodies for research focused on understanding Vif protein's role in HIV-1 pathogenesis. Multiple detection methods are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The HIV-1 Vif protein plays a vital role in helping the virus evade host immune responses by counteracting the antiviral effects of the APOBEC3 family of proteins. Through promoting degradation of host restriction factors, Vif enhances viral replication and contributes to HIV-1 infection persistence. Research into HIV-1 Vif mechanisms continues to reveal new insights about viral immune evasion strategies. Understanding Vif's molecular interactions helps identify novel therapeutic approaches for HIV treatment. Investigating Vif's role in viral pathogenesis advances knowledge of host-pathogen relationships. Ongoing studies of HIV-1 Vif provide critical information for developing targeted antiviral strategies. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to conduct detailed studies of HIV-1 Vif, supporting scientific advances in HIV/AIDS research and therapeutic development.

SEE ALSO...

Empty Table HeaderProduct NameCATALOG #ISOTYPEEPITOPEAPPLICATIONSSpeciesCitationsRATING

HIV-1 Vif Antibody (319)

sc-69731mouse IgG1 κ(HIV-1)WB, IFHIV-1
6
(2)